Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma
Clinical trial NCT02724878 · COMPLETED
Trial details
- NCT number
- NCT02724878
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-15
- Primary completion
- 2019-11-13
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.